
Seres Therapeutics MCRB
$ 4.54
1.34%
Country |
|
IPO year |
2015 |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ GLOBAL |
Shares |
8.86 M |
Market Cap[1] |
$ 40.2 M |
EBITDA (LTM) |
$ -84.4 M |
P/E (LTM) |
-4.07 |
P/S (LTM) |
2.07 |
EPS (LTM) |
-1.19 |
Other stocks of industry "Biotechnology"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
|
Celsion Corporation
CLSN
|
- | -6.63 % | $ 13.9 M | Nasdaq Capital Market | ||
|
FSD Pharma
HUGE
|
- | 5743.5 % | $ 69.7 M | Nasdaq Capital Market | ||
|
Qilian International Holding Group Limited
QLI
|
- | -6.08 % | $ 184 M | Nasdaq Global Select Market | ||
|
Happiness Biotech Group Limited
HAPP
|
- | 1.35 % | $ 17.8 M | Nasdaq Capital Market | ||
|
Synthetic Biologics
SYN
|
- | 1.32 % | $ 16.2 M | NYSE American | ||
|
Dynavax Technologies Corporation
DVAX
|
- | - | $ 2.02 B | Nasdaq Capital Market | ||
|
BioXcel Therapeutics
BTAI
|
$ 1.19 | 5.31 % | $ 14.5 M | Nasdaq Global Select Market,SPB | ||
|
Burford Capital Limited
BUR
|
$ 4.37 | 0.23 % | $ 958 M | NYSE | ||
|
I-Mab
IMAB
|
- | - | $ 866 M | Nasdaq Global Select Market | ||
|
BeyondSpring
BYSI
|
$ 0.84 | 34.27 % | $ 34.5 M | Nasdaq Capital Market | ||
|
Corner Growth Acquisition Corp.
COOL
|
- | -0.89 % | $ 114 M | Nasdaq Global Select Market | ||
|
AgeX Therapeutics
AGE
|
- | -10.17 % | $ 12.2 K | NYSE American | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
- | - | $ 40.3 B | Nasdaq Global Select Market | ||
|
Genfit SA
GNFT
|
- | 2.54 % | $ 160 B | Nasdaq Global Select Market | ||
|
Biophytis SA
BPTS
|
- | -13.47 % | $ 169 M | Nasdaq Capital Market | ||
|
Cerus Corporation
CERS
|
$ 2.98 | 4.93 % | $ 568 M | Nasdaq Global Market | ||
|
Compugen Ltd.
CGEN
|
$ 2.41 | 4.17 % | $ 225 M | Nasdaq Global Market,SPB | ||
|
CureVac N.V.
CVAC
|
- | - | $ 867 M | Nasdaq Global Market | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
- | -1.52 % | $ 24.7 M | Nasdaq Capital Market | ||
|
Athira Pharma
ATHA
|
- | - | $ 269 M | Nasdaq Global Select Market | ||
|
BiondVax Pharmaceuticals Ltd.
BVXV
|
- | 0.74 % | $ 768 M | Nasdaq Capital Market | ||
|
Abcam plc
ABCM
|
- | - | $ 4.9 B | Nasdaq Global Select Market | ||
|
Завод ДИОД
DIOD
|
- | - | - | MOEX,SPB | ||
|
Galera Therapeutics
GRTX
|
- | -32.59 % | $ 7.61 M | Nasdaq Global Market | ||
|
Midatech Pharma plc
MTP
|
- | -18.52 % | $ 27.3 M | Nasdaq Global Select Market | ||
|
Hepion Pharmaceuticals
HEPA
|
- | -18.79 % | $ 39.3 K | Nasdaq Capital Market | ||
|
ARCA biopharma
ABIO
|
- | 1052.0 % | $ 415 M | Nasdaq Capital Market | ||
|
MorphoSys AG
MOR
|
- | 2.43 % | $ 254 M | Nasdaq Global Select Market | ||
|
Champions Oncology
CSBR
|
$ 5.1 | 2.63 % | $ 70.5 M | Nasdaq Capital Market | ||
|
Affimed N.V.
AFMD
|
- | -34.95 % | $ 21.5 M | Nasdaq Global Select Market,SPB | ||
|
AnPac Bio-Medical Science Co., Ltd.
ANPC
|
- | -1.58 % | $ 28.1 M | Nasdaq Global Market | ||
|
Celyad Oncology SA
CYAD
|
- | - | $ 12.5 M | Nasdaq Global Market | ||
|
Adial Pharmaceuticals
ADIL
|
$ 3.98 | 1.86 % | $ 2.66 M | Nasdaq Capital Market | ||
|
Generation Bio Co.
GBIO
|
- | - | $ 344 M | Nasdaq Global Select Market | ||
|
Akero Therapeutics
AKRO
|
- | - | $ 3.67 B | Nasdaq Global Select Market,SPB | ||
|
AnaptysBio
ANAB
|
$ 58.47 | 4.37 % | $ 1.68 B | Nasdaq Global Select Market,SPB | ||
|
Anika Therapeutics
ANIK
|
$ 21.5 | 1.56 % | $ 308 M | Nasdaq Global Select Market,SPB | ||
|
Cyclacel Pharmaceuticals
CYCCP
|
- | -4.36 % | $ 27 M | Nasdaq Capital Market | ||
|
Gracell Biotechnologies
GRCL
|
- | - | $ 3.37 B | Nasdaq Global Select Market | ||
|
Aurinia Pharmaceuticals
AUPH
|
$ 15.47 | 1.91 % | $ 2.08 B | Nasdaq Global Market | ||
|
GlycoMimetics
GLYC
|
- | 9357.83 % | $ 1.01 B | Nasdaq Global Market | ||
|
Aeterna Zentaris
AEZS
|
- | 5.93 % | $ 314 M | Nasdaq Capital Market | ||
|
AVROBIO
AVRO
|
- | 1083.1 % | $ 745 M | Nasdaq Global Select Market | ||
|
BeiGene, Ltd.
BGNE
|
- | 0.49 % | $ 251 B | Nasdaq Global Select Market | ||
|
Bicycle Therapeutics plc
BCYC
|
$ 3.9 | 0.24 % | $ 270 M | Nasdaq Global Select Market | ||
|
Beam Therapeutics
BEAM
|
$ 26.75 | 0.91 % | $ 2.65 B | Nasdaq Global Select Market | ||
|
AIkido Pharma
AIKI
|
- | 1.93 % | $ 17.4 M | Nasdaq Capital Market | ||
|
Aeglea BioTherapeutics
AGLE
|
- | - | $ 1.01 B | Nasdaq Global Market | ||
|
BioMarin Pharmaceutical
BMRN
|
$ 67.36 | 0.99 % | $ 12.9 B | Nasdaq Global Select Market,SPB | ||
|
Aptose Biosciences
APTO
|
- | -45.71 % | $ 1.2 M | Nasdaq Capital Market |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.